首页> 外国专利> Preparation and purification method of recombinant human fibrost growth factor receptor by using solubility-enhancing bifunctional fusion tag combined with split intein and use thereof

Preparation and purification method of recombinant human fibrost growth factor receptor by using solubility-enhancing bifunctional fusion tag combined with split intein and use thereof

机译:通过使用溶解性增强的双官能融合标签与分裂意识形来的制备和纯化方法通过溶解性增强的双功能融合标签及其用途

摘要

The present invention relates to a method for preparing a human recombinant fibroblast growth factor receptor using a solubility-enhancing bifunctional fusion tag grafted with a split intein, a purification method, and a use thereof, and more particularly produced a dual-functional tag with improved solubility by fusing the carboxyl-terminal region of the split intein with a fusion partner for improved solubility, and fusing it to the amino-terminus of the extracellular domain of human fibroblast growth factor receptor. The present invention relates to a method for preparing a recombinant human fibroblast growth factor receptor with improved solubility, and processing the amino-terminal region of a split intein therefrom to simultaneously remove a dual functional fusion tag and purify a protein, wherein the solubility is improved through the present invention By allowing the production of the extracellular domain (Ec-FGFR) of the fibroblast growth factor receptor (Ec-FGFR) and the removal of the affinity tag to occur simultaneously, the process is simplified and economical compared to the conventional method, and it is possible to secure the structural uniformity of the domain, It can be usefully utilized in the development of pharmaceutical compositions for diagnosis and treatment of various diseases.
机译:本发明涉及使用溶解性增强的分离内氨肽,纯化方法和其用途的溶解度增强的双官能融合标签制备人重组成纤维细胞生长因子受体的方法,更具体地制备了具有改进的双功能标签通过将分离内蛋白的羧基末端区域与融合合作伙伴融合,以改善溶解度,并将其融合到人成纤维细胞生长因子受体的细胞外结构域的氨基末端来溶解。本发明涉及一种制备重组人成纤维细胞生长因子受体的方法,其具有改进的溶解度,并从中加工分裂嵌体的氨基 - 末端区域,以同时除去双功能融合标签并净化蛋白质,其中溶解度得到改善通过本发明通过允许产生成纤维细胞生长因子受体(EC-FGFR)的细胞外结构域(EC-FGFR)并同时去除亲和标签,与常规方法相比,该方法简化和经济并且可以确保该结构域的结构均匀性,可以有效地利用在发育药物组合物中用于诊断和治疗各种疾病的药物组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号